Medicine
STAT+: Pharmalittle: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and more
Three former FDA chiefs lit into the Trump administration, criticizing the now former FDA officials who oversaw a massive staff exodus
STAT+: ‘AI sandboxes’ are all the rage. Advocates scramble to control their future
In this edition of STAT's Health Tech newsletter: The groups vying to shape regulations that'd govern state AI sandboxes, and more.
Kenya reports second Ebola case
Kenya reports a second Ebola case. Meanwhile, the situation in Congo is still quite dire. Authorities have confirmed more than 4,000 deaths and 9,000 cases as officials have strug…
STAT+: On Wall Street, there’s trouble stirring for biotech
On Wall Street, the real trouble for biotech, and the reason for investor angst, lies below the surface.
The hidden costs of fracking: boom in Argentina linked to trail of sickness
Families in Vaca Muerta, the centre of Patagonia’s shale operation, report cancers, miscarriages and pollutionIn Allen, a small town in Argentine Patagonia, many people living on …
Opinion: My daughter’s death changed how I understood the nursing shortage
Health systems invest in training, but lose early-career nurses within a few years.
Opinion: MyChart said I could opt out of sharing my health data. Figuring out how was maddening
Want to opt out of sharing your personal health data? You may need a notary, writes Alex Rosenblat.
Forty percent of high school students report binge eating in new CDC survey
About 40% of high school students reported binge-eating in the past month in a new CDC survey, highlighting how widespread this form of disordered eating is among young people.
Compass Pathways CEO: Psychedelics company will ‘go slow before we go fast’
The CEO of Compass Pathways said the company, whose psychedelic therapy is set for regulatory review this year, is prepared to “go slow before we go fast.”
Former FDA officials blast DOGE as ‘one of the biggest disasters in American history’
Three former FDA chiefs criticized the DOGE cuts to the agency, saying they robbed the FDA of institutional knowledge that will take years to restore.
As White House shifts focus toward AI and tech, U.S. science leaders defend role of the American university
White House planned shift of research funding from universities to industry risks creating a drought in basic research, science leaders say
STAT+: Trump administration delays new rule that could restrict imported medicines from Canada and overseas
The Trump administration is delaying by 90 days a federal rule that could prevent Americans from obtaining prescription drugs from licensed international pharmacies.
How consumer tech company Whoop is building for Medicare patients
Whoop's chief medical officer, said the company's work with Medicare is an opportunity to prove its ability to improve health at the population level.
‘Try to eat really well, 80% of the time’: nutrition expert says healthy eating is easier than you think
Christopher Gardner, the author of Food Sense and director of nutrition studies at Stanford, says we have overcomplicated the question of what to eatFinally, some good news: eatin…
STAT+: FDA adcomm members’ ties to industry under scrutiny
New research found that nearly 40% of FDA advisory meetings held over a recent 20-year period included either a patient or consumer rep with active ties to an advocacy group…
STAT+: Pharmalittle: We’re reading about Sanofi settling an EU antitrust probe, ‘pharma bro’ Shkreli, and more
The FTC asked a U.S. court to hold Martin Shkreli in contempt for “flagrantly” violating a court order banning him from working in the pharma industry
STAT+: The startup chasing ‘general biological intelligence’
In this edition of AI Prognosis, Brittany Trang talks to Eric Nguyen, the CEO of Radical Numerics, a startup pursuing "general biological intelligence.'
STAT+: Sanofi avoids fine as EU accepts offer to end antitrust probe over disparaging rival vaccine
E.U. antitrust regulators accepted concessions from Sanofi to settle a probe into an allegedly “misleading” campaign that disparaged a rival flu vaccine.
New study examines GLP-1 impact on interactions with criminal justice system, employment, housing stability
A wave of clinical trials have begun to test the ability of GLP-1 weight loss drugs to quell various substance use disorders, with some promising results. A new trial announced…
Family of man killed by tiger criticise online content after Trump reposts video
Relatives of William Chapman say footage of attack shared online ‘deeply offensive’ and causing them ‘severe distress’The family of a man killed by a tiger at a wildlife park in t…
What to know about Pope Leo's lung cancer diagnosis
NPR's Steve Inskeep speaks to Dr. Otis Brawley, an oncologist at Johns Hopkins University, about the Pope's lung cancer diagnosis.
Opinion: We think a baby’s gut microbiome could be key to lifelong brain health
“We need more rigorous, large-scale research into the gut-brain axis across the life course,” write Holly Baines and George Vradenburg.
Opinion: How states can resist the potential Trump vaccine shortages
“States can serve as a last line of defense against the Trump administration’s anti-vaccine policy,” writes Joel Dodge.
STAT+: Lobbyists and trade groups fight to shape how states regulate medical AI
Lobbying groups for doctors and hospitals and trade groups are working behind the scenes on how to regulate AI in medicine.